Sustained release ivermectin-loaded solid lipid dispersion for subcutaneous delivery: in vitro and in vivo evaluation

References

• Bassissi F, Lespine A, Alvinerie M. (2006). Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration. Parasitol Res 98:244–9
   PubMed Web of Science ®Google Scholar
• Bowman DD, Fogelson ML, Carbone LG. (1992). Effect of ivermectin on the control of ear mites (Psoroptes cuniculi) in naturally infested rabbits. Am J Vet Res 53:105–9
   PubMed Web of Science ®Google Scholar
• Camargo JA, Sapin A, Daloz D, et al. (2010). Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables. J Microencapsul 27:609–17
   PubMed Web of Science ®Google Scholar
• Chaccour C, Barrio A, Gil Royo AG, et al. (2015). Screening for an ivermectin slow-release formulation suitable for malaria vector control. Malar J 14:102
   PubMed Web of Science ®Google Scholar
• Chokshi RJ, Zia H, Sandhu HK, et al. (2007). Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons. Drug Deliv 14:33–45
   PubMed Web of Science ®Google Scholar
• De Meirleir N, Pellens L, Broeckx W, et al. (2013). The emulsion crystallization of hydrogenated castor oil into long thin fibers. J Crystal Growth 383:51–6
   Web of Science ®Google Scholar
• Dong J, Song X, Lian X, et al. (2014). Subcutaneously injected ivermectin-loaded mixed micelles: formulation, pharmacokinetics and local irritation study. Drug Deliv 23:2220–7
   PubMed Web of Science ®Google Scholar
• Flynn RJ. (1973). Parasites of laboratory animals. Ames, IA: Iowa State Press
   Google Scholar
• Giri TK, Kumar K, Alexander A, et al. (2012). A novel and alternative approach to controlled release drug delivery system based on solid dispersion technique. Bull Faculty of Pharmacy, Cairo University 50:147–59
   Google Scholar
• Kennedy M, Hu J, Gao P, et al. (2008). Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. Mol Pharm 5:981–93
   PubMed Web of Science ®Google Scholar
• Kohri N, Yamayoshi Y, He X. (1999). Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol 51:159–64
   PubMed Web of Science ®Google Scholar
• Li W, Yang Y, Wang C, et al. (2012). Carrier-free, functionalized drug nanoparticles for targeted drug delivery. Chem Commun (Camb) 48:8120–2
   PubMed Web of Science ®Google Scholar
• Lo PK, Fink DW, Williams JB, et al. (1985). Pharmacokinetic studies of ivermectin: effects of formulation. Vet Res Commun 9:251–68
   PubMed Web of Science ®Google Scholar
• Mellgren M, Bergvall K. (2008). Treatment of rabbit cheyletiellosis with selamectin or ivermectin: a retrospective case study. Acta Veterinaria Scand 50:1–6
   PubMed Web of Science ®Google Scholar
• Molinari G, Soloneski S, Reigosa MA, et al. (2009). In vitro genotoxic and cytotoxic effects of ivermectin and its formulation ivomec on Chinese hamster ovary (CHOK1) cells. J Hazard Mater 165:1074–82
   PubMed Web of Science ®Google Scholar
• Nong X, Ren YJ, Wang JH, et al. (2013). Clinical efficacy of botanical extracts from Eupatorium adenophorum against the scab mite, Psoroptes cuniculi. Vet Parasitol 192:247–52
   PubMed Web of Science ®Google Scholar
• O'brien DJ, Gray JS, O'reilly PF. (1994). Survival and retention of infectivity of the mite Psoroptes ovis off the host. Vet Res Commun 18:27–36
   PubMed Web of Science ®Google Scholar
• Oh DH, Park YJ, Kang JH, et al. (2011). Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. Drug Deliv 18:46–53
   PubMed Web of Science ®Google Scholar
• Okonogi S, Puttipipatkhachorn S. (2006). Dissolution improvement of high drug-loaded solid dispersion. AAPS PharmSciTech 7:E1–E6
   PubMed Web of Science ®Google Scholar
• Omura S. (2008). Ivermectin: 25 years and still going strong. Int J Antimicrob Agents 31:91–8
   PubMed Web of Science ®Google Scholar
• Rehbein S, Baggott DG, Johnson EG, et al. (2013). Nematode burdens of pastured cattle treated once at turnout with eprinomectin extended-release injection. Vet Parasitol 192:321–31
   PubMed Web of Science ®Google Scholar
• Rolim LA, Dos Santos FCM, Chaves LL, et al. (2015). Preformulation study of ivermectin raw material. J Therm Anal Calorim 120:807–16
   Web of Science ®Google Scholar
• Rosiaux Y, Jannin V, Hughes S, et al. (2014). Solid lipid excipients – matrix agents for sustained drug delivery. J Control Release 188:18–30
   PubMed Web of Science ®Google Scholar
• Rothen-Weinhold A, Gurny MD. (2000). Formulation and technology aspects of conrolled drug delivery in animals. Pharm Sci Technol Today 3:222–31
   PubMedGoogle Scholar
• Sahoo J, Murthy PN, Biswal S, et al. (2009). Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR. AAPS PharmSciTech 10:27–33
   PubMed Web of Science ®Google Scholar
• Shah BM, Panda S, Reddy CU. (2012). Formulation and evaluation of sustained release matrix tablets of verapamil hydrochloride by melt granulation. Int J Pharmacy Pharm Sci 4:501–7
   Google Scholar
• Singh D, Pathak K. (2013). Hydrogen bond replacement–unearthing a novel molecular mechanism of surface solid dispersion for enhanced solubility of a drug for veterinary use. Int J Pharm 441:99–110
   PubMed Web of Science ®Google Scholar
• Tanaka N, Imai K, Okimoto K, et al. (2005). Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J Control Release 108:386–95
   PubMed Web of Science ®Google Scholar
• Ozeki T, Yuasa H, Okada H. (2005). Controlled release of drug via methylcellulose-carboxyvinylpolymer interpolymer complex solid dispersion. AAPS PharmSciTech 6:E231–6
   PubMed Web of Science ®Google Scholar
• Thiry J, Lebrun P, Vinassa C, et al. (2016). Continuous production of itraconazole-based solid dispersions by hot melt extrusion: preformulation, optimization and design space determination. Int J Pharm 515:114–24
   PubMed Web of Science ®Google Scholar
• Tran PH, Tran TT, Park JB, et al. (2011). Controlled release systems containing solid dispersions: strategies and mechanisms. Pharm Res 28:2353–78
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Faghihian H, Rastgoo K. (2006). Preparation and characterization of metoprolol controlled-release solid dispersions. Drug Deliv 13:295–302
   PubMed Web of Science ®Google Scholar
• Voyvoda H, Ulutas B, Eren H, et al. (2005). Use of doramectin for treatment of sarcoptic mange in five Angora rabbits. Vet Dermatol 16:285–8
   PubMed Web of Science ®Google Scholar
• Xie S, Pan B, Wang M, et al. (2010). Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles. Nanomedicine 5:693–701
   PubMed Web of Science ®Google Scholar
• Xie S, Wang F, Wang Y, et al. (2011). Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles. Particle Fibre Toxicol 8:33
   PubMed Web of Science ®Google Scholar
• Xu FR, Pan BL, Wang YW, et al. (2007). Pharmacokinetics of injectable long-acting ivermectin aqueous suspension following subcutaneous administration in sheep. J Vet Pharmacol Ther 30:486–8
   PubMed Web of Science ®Google Scholar
• Yan YD, Sung JH, Kim KK, et al. (2012). Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm 422:202–10
   PubMed Web of Science ®Google Scholar
• Yang D, Hrymak AN. (2011). Crystal morphology of hydrogenated castor oil in the crystallization of oil-in-water emulsions: Part I. Effect of temperature. Ind Eng Chem Res 50:11585–93
   Web of Science ®Google Scholar